Company: JACS-RI
Filing Date: 2025-03-18
Form Type: 10-K
Source: 0001013762-25-000620
Chunk: 179

Company: Jackson Acquisition Co II
Filing Date: 2025-03-18
Form: 10-K
Item: Item 1A
Chunk 179
---
 the boards of directors of the Giving Company and the Family Christian Resource Center.

We believe that Mr. Jackson’s
extensive experience as a healthcare entrepreneur and investor, as well as his extensive industry contacts and experience, qualify him
to serve as a member of our board of directors.

David Lawrence has
served as our Chief Financial Officer since September 2024. Mr. Lawrence has over twenty years of financial and operational
leadership experience in the biotechnology industry. From March 2021 to November 2023, Mr. Lawrence served as Chief Financial
Officer of Neurotrauma Sciences, LLC. From 1999 to March 2021, Mr. Lawrence served at Acorda Therapeutics, Inc. (Nasdaq:
ACOR) in several financial and operational positions including Chief of Business Operations and Principal Accounting Officer from 2016
to March 2021, Chief of Business Operations from 2013 to 2016, Chief Financial Officer from 2005 to 2013 and Vice President of Finance
from 2001 to 2004. While at Acorda Therapeutics, Mr. Lawrence managed the successful completion of the company’s IPO and managed
several follow-on offerings and private placements raising a total of over seven hundred million dollars. Mr. Lawrence’s prior
experience includes financial management positions of Vice President and Controller and Finance Manager for several telecommunication
companies including Southwestern Bell and Metromedia Telecommunications. Mr. Lawrence received his B.A. in Accounting from Roger
Williams College and an MBA in Finance from Iona University in New York.

28

Brian A. McCarthy
has served as an independent director since December 2024. Mr. McCarthy has served as a member of Patient Square’s Advisory
Council since May 2023. Over the course of his career, he has served as a financial advisor on over 125 health care transactions
representing an aggregate transaction value in excess of $100 billion. From 2012 to August 2022, Mr. McCarthy served in
various roles in the Healthcare Investment Banking Group at Bank of America, most recently as Vice Chairman. In this role, he was responsible
for many of the bank’s most important healthcare clients. Prior to Bank of America, Mr. McCarthy served as the Head of the
Healthcare Investment Banking Group at Oppenheimer & Co. Inc., from